Lyna Haybout
4PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 10, 2026
Alistipes and Eggerthella shape the response to oncolytic adenovirus therapy in mice and humans through short-chain fatty acid metabolism.Mirte van der Heijden, James Hugo Armstrong Clubb, Pande Putu Erawijantari
|Apr 10, 2025
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes.Tatiana V Kudling, Dmitrii Bychkov, James H A Clubb
|Feb 05, 2025
The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial.Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää
|Mar 28, 2024
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial.Santeri A Pakola, Katriina J Peltola, James H A Clubb
Pageof 1
Frequent Collaborators
4 joint publications
Santeri Pakola
4 joint publications
Elise Jirovec
3 joint publications
Akseli Hemminki
3 joint publications
Tatiana V Kudling
3 joint publications
Riikka Havunen
2 joint publications
James Hugo Armstrong Clubb
2 joint publications
Tuomo Alanko
2 joint publications
Mirte van der Heijden
2 joint publications
Jorma Sormunen
2 joint publications
Teijo Pellinen
